Inhaled beclomethasone in the treatment of early COVID-19: a double blind, placebo-controlled trial
C. Ranasinha (Ragama, Sri Lanka), C. Mettananda (Ragama, Sri Lanka), A. Pathmeswaran (Ragama, Sri Lanka), C. Peiris (Ragama, Sri Lanka), A. Gunasekara (Ragama, Sri Lanka), D. Abeyrathna (Ragama, Sri Lanka), T. Egodage (Ragama, Sri Lanka), C. Dantanarayana (Ragama, Sri Lanka)
Source: International Congress 2022 – COVID treatments
Session: COVID treatments
Session type: Thematic Poster
Number: 2600
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Ranasinha (Ragama, Sri Lanka), C. Mettananda (Ragama, Sri Lanka), A. Pathmeswaran (Ragama, Sri Lanka), C. Peiris (Ragama, Sri Lanka), A. Gunasekara (Ragama, Sri Lanka), D. Abeyrathna (Ragama, Sri Lanka), T. Egodage (Ragama, Sri Lanka), C. Dantanarayana (Ragama, Sri Lanka). Inhaled beclomethasone in the treatment of early COVID-19: a double blind, placebo-controlled trial. 2600
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|